ColossalのAI、試験用に約2,300件のドードー遺伝子編集ターゲットをマッピング
ColossalのCEOであるBen Lammは、GenoMorphが70種を超える鳥類のデータを用いて編集の優先順位を決めていると述べた。これらの予測は依然として実験室で検証する必要がある。
By RuntimeWire Staff · Published
Primary source: TechCrunch
なぜ重要なのか
GenoMorphは、Colossalが絶滅種復活研究を計算生物学インフラへと変えつつあることを示している。その2,300件のドードー標的は、検証済みの編集や商用製品の証明ではなく、あくまで実験の出発点に過ぎない。
Colossal says its GenoMorph AI combines developmental and comparative data from more than 70 bird species to prioritize roughly 2,300 candidate gene-editing targets tied to dodo appearance. The company emphasizes these are testable hypotheses, not validated edits, and plans lab experiments using lipid nanoparticles and Nicobar pigeon cells to evaluate effects. The announcement also drew an outside financing signal via NeoGenesis Capital, while GenoMorph is presented as an internal research tool rather than a commercial product.
Colossal Biosciences co-founder and CEO Ben Lamm says Colossal has built an AI platform to help researchers choose which genetic changes to test as it works toward recreating dodo traits. The system, called GenoMorph, has surfaced approximately 2,300 candidate targets, according to TechCrunch's report on the October 14th announcement.…
When you purchase through links in our articles, we may earn a small commission. This doesn’t affect our editorial independence.